Semaglutide, lipid-lowering drugs, and NAFLD.
| Title | Semaglutide, lipid-lowering drugs, and NAFLD. |
| Publication Type | Journal Article |
| Year of Publication | 2017 |
| Authors | Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. |
| Journal | Lancet Diabetes Endocrinol |
| Volume | 5 |
| Issue | 5 |
| Pagination | 329-330 |
| Date Published | 2017 05 |
| ISSN | 2213-8595 |
| Keywords | Glucagon-Like Peptides, Humans, Hypoglycemic Agents, Lipids, Non-alcoholic Fatty Liver Disease |
| DOI | 10.1016/S2213-8587(17)30109-2 |
| Alternate Journal | Lancet Diabetes Endocrinol |
| PubMed ID | 28434490 |
